Scour Bos 4 (Canada)This page contains information on Scour Bos 4 for veterinary use.
The information provided typically includes the following:
- Scour Bos 4 Indications
- Warnings and cautions for Scour Bos 4
- Direction and dosage information for Scour Bos 4
Scour Bos 4This treatment applies to the following species:
Bovine Rotavirus Coronavirus Vaccine
For Use In Animals Only
Scour Bos 4 Indications
For use in healthy pregnant cattle as an aid in the prevention of disease in calves caused by bovine rotavirus and bovine coronavirus.
ADJUVANT: Xtend™ III.
Directions For Use
Shake well before using. Administer 2 mL intramuscularly in the neck 8-16 weeks prior to calving. Repeat 4 weeks prior to calving. Revaccinate with one dose 8-10 weeks prior to each subsequent calving.
PrecautionsStore out of direct sunlight at 2°-8°C (35°-46°F). DO NOT FREEZE. Do not mix with other products, except as specified on the label. In case of human exposure, contact a physician. Use entire contents when first opened. Do not vaccinate within 60 days prior to slaughter. It is essential that newborn calves receive colostrum from the vaccinated dam.
WarningTHIS PRODUCT MAY CAUSE PERSISTENT SWELLING AT THE SITE OF INJECTION. Anaphylactic reactions may occur. Symptomatic treatment: Epinephrine. Contains amphotericin B, gentamicin, and thimerosal as preservatives.
Manufactured by Elanco US Inc., Larchwood, IA, USA.
USDA Vet. Biologics Est. Lic. No. 196.
For Elanco Canada Limited, Guelph, Ontario, Canada N1G 4T2; 1-800-265-5475.
Scour Bos, Xtend, Elanco and the diagonal bar logo are trademarks of Eli Lilly and Company or its affiliates.
(successor to Novartis Animal Health Canada Inc.)
RESEARCH PARK CENTRE, 150 RESEARCH LANE, SUITE 120, GUELPH, ON, N1G 4T2
|Every effort has been made to ensure the accuracy of the Scour Bos 4 information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the Canadian product label or package insert.|
Copyright © 2018 Animalytix LLC. Updated: 2018-09-28